News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novo Nordisk A/S (NVO) Steps Up Research to Find Cure for Diabetes, Plans to Hire More Researchers


5/7/2012 8:23:19 AM

About 3 million Americans have Type 1 diabetes, which can be treated with daily shots of insulin but can't be cured. A big player in diabetes, Danish drug company Novo Nordisk, is expanding its research efforts in Seattle in hopes of making progress toward a cure. The company already employs 71 people at the Seattle research center on inflammatory diseases it opened in 2009. Next month it will launch a diabetes-research effort here, led by Dr. Matthias von Herrath, director of the nonprofit Center for Type 1 Diabetes Research in La Jolla, California. It's set to open June 14 in Novo Nordisk's facilities in South Lake Union.

Read at News Release
Read at Seattle Times

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES